These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 17638620

  • 21. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 22. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J, Klaiber E, Wiita B, Bowen A, Yang HM.
    Menopause; 1999 Apr; 6(2):138-46. PubMed ID: 10374221
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR, Dinatale I, Rivera-Woll L, Davison S.
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR, Duncan A, Sedlacek S, Paul D, Holmes F, Vukelja S, Kasper M, Wilks S, Schneider A, McGee R, Meyer WG, O'Shaughnessy JA.
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H.
    Maturitas; 2005 May 16; 51(1):83-97. PubMed ID: 15883113
    [Abstract] [Full Text] [Related]

  • 29. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L, Bixo M, Hirschberg AL, Sundström-Poromaa I, Hammar M.
    Menopause; 2010 May 16; 17(1):72-9. PubMed ID: 19675505
    [Abstract] [Full Text] [Related]

  • 30. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.
    Menopause; 2008 May 16; 15(1):51-8. PubMed ID: 18257142
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D, Posea C, Ceausu I, Rusu M.
    Eur Rev Med Pharmacol Sci; 2003 May 16; 7(5):117-25. PubMed ID: 15214586
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hormone replacement therapy in postmenopausal women.
    Yasui T, Uemura H, Takikawa M, Irahara M.
    J Med Invest; 2003 Aug 16; 50(3-4):136-45. PubMed ID: 13678382
    [Abstract] [Full Text] [Related]

  • 34. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
    Skouby SO, Barlow D, Samsioe G, Gompel A, Pines A, Al-Azzawi F, Graziottin A, Hudita D, Rozenberg S, European Menopause and Andropause Society (EMAS).
    Maturitas; 2004 May 28; 48(1):19-25. PubMed ID: 15223104
    [Abstract] [Full Text] [Related]

  • 37. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M.
    J Cardiovasc Med (Hagerstown); 2009 Apr 28; 10(4):303-9. PubMed ID: 19430340
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF.
    Semin Reprod Med; 2005 May 28; 23(2):188-95. PubMed ID: 15852205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.